RNA as a target for small molecules

Current Opinion in Chemical Biology

Volumn 4, Issue 6, 2000, Pages 678-686

  Sucheck, Steven J ^a   Wong, Chi Huey ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXYSTREPTAMINE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC G 418; APRAMYCIN; GENTAMICIN; HOE 33342; HOECHST 33348; HYGROMYCIN B; KANAMYCIN; NEOMYCIN; PAROMOMYCIN; RNA; SPECTINOMYCIN; STREPTOMYCIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

CATALYSIS; DRUG BINDING SITE; DRUG STRUCTURE; DRUG TARGETING; GENE EXPRESSION SYSTEM; PROTEIN FOLDING; PROTEIN RNA BINDING; REVIEW; RNA SEQUENCE;

EID: 0033635335     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00142-3     Document Type: Review

References (67)

1. RNA as a drug target: Chemical, modelling, and evolutionary tools
2. RNA and the small molecule world
3. RNA as small-molecule drug target: Doubling the value of genomics
4. Strategies for the design of drugs targeting RNA and RNA-protein complexes
5. The 3' terminus of 16S rRNA: Secondary structure and interaction with ribosomal protein S1
6. Placement of protein and RNA structures into a 5 Å-resolution map of the 50S ribosomal subunit
7. Tertiary motifs in RNA structure and folding
8. Structure of the S15, S6, S18-rRNA complex: Assembly of the 30S ribosome central domain
9. Specific binding of aminoglycoside antibiotics to RNA
10. Selection of RNA-binding peptides in vivo
11. Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex
12. Recent solution structures of RNA and its complexes with drugs, peptides and proteins
13. RNA recognition by the human immunodeficiency virus Tat and Rev proteins
14. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 Tat protein requires basepairs in the RNA stem and amino acid residues flanking the basic region
15. Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics
16. Inhibitors of protein-RNA complexation that target the RNA: Specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules
17. A new class of HIV-1 Tat antagonist acting through Tat-TAR Inhibition
18. Molecular basis of HIV-1 TAR RNA specific recognition by an acridine Tat-antagonist
19. Dual interference of hygromycin B with ribosomal translocation and with aminoacyl-tRNA recognition
20. Interaction of kanamycin and related antibiotics with the large subunit of ribosomes and the inhibition of translocation
21. Functional interaction of neomycin B and related antibiotics with 30S and 50S ribosomal subunits
22. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
23. Controlling gene expression in living cells through small molecule-RNA interations
24. Fused transcript of Abl and Bcr genes in chronic myelogenous leukemia
25. Signal transduction by wild-type and leukemogenic Abl proteins
26. Design of small molecules that recognize RNA: Development of aminoglycosides as potential antitumor agents that target oncogenic RNA sequences
27. Role of hemagglutinin cleavage for the pathogenicity of influenza Virus
28. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
29. Processing of the Ebola virus glycoprotein
30. Multiplexed screening of neutral mass-tagged RNA targets against ligand libraries with electrospray ionization FTICR MS: A paradigm for high-throughput affinity screening
31. Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry
32. High density synthetic oligonucleotide arrays
33. Interaction of antibiotics with functional sites in 16S ribosomal RNA
34. Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA
35. Binding sites of the antibiotics pactamycin and celesticetin on ribosomal RNAs
36. Interaction of tetracycline with RNA: Photoincorporation into ribosomal RNA of Escherichia coli
37. Puromycin-rRNA interaction sites at the peptidyl transferase center
38. An antibiotic-binding motif of an RNA fragment derived from the A-site-related region of Escherichia-coli 16S rRNA
39. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region
40. RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide
41. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic
42. Structural origins of gentamicin antibiotic action
43. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA
44. Spectinomycin interacts specifically with the residues G1064 and C1192 in 16S rRNA, thereby potentially freezing this molecule into an inactive conformation
45. Ribosomal RNA and protein mutants resistant to spectinomycin
46. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism
47. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production
48. Rapid combinatorial synthesis of aminoglycoside antibiotic mimetics: Use of a polyethylene glycol-linked amine and a neamine-derived aldehyde in multiple component condensation as a strategy for the discovery of new inhibitors of the HIV RNA Rev responsive element
49. Hydroxyamines as a new motif for the molecular recognition of phosphodiesters: Implications for aminoglycoside-RNA interactions
50. Design of bifunctional antibiotics that target bacterial RNA and inhibit resistance-causing enzymes
51. Enhanced RNA binding of dimerized amino glycosides
52. Footprinting the sites of interaction of antibiotics with catalytic group I intron RNA
53. Inhibition of the hammerhead ribozyme by neomycin
54. Inhibition of hepatitis delta virus genomic ribozyme self-cleavage by aminoglycosides
55. Designing novel RNA binders
56. Structure-based and combinatorial search for new RNA-binding drugs
57. Structure-based discovery of ligands targeted to the RNA double helix
58. Design and analysis of molecular motifs for specific recognition of RNA
59. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance
60. A high-throughput fluorescence screen to monitor the specific binding of antagonists to RNA targets
61. An antibiotic cloaked by its own resistance enzyme
62. Simple aminols as aminoglycoside surrogates
63. Neomycin-acridine conjugate: A potent inhibitor of Rev-RRE binding
64. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives
65. Importance of ribosomal frameshifting for human immunodeficiency virus type I particle assembly and replication
66. Mechanism of action of the oxazolidinone antibacterial agents
67. Interaction of thiostrepton with an RNA fragment derived from the plastid-encoded ribosomal RNA of the malaria parasite